\
&
Contact us
\
&
Contact us
This was 3 years ago
LocationClaridge or online (via zoom)
The EIT Culture & Creativity’s Moonshot event provides an opportunity to establish a long-term and ambitious shared goal for the competitiveness of the European Cultural and Creative Sectors and Industries (CCSI) and their critical role in the future of Europe.
This event will include the participation of relevant representatives from the European Parliament, the European Commission, Member States, regions, and cities, as well as the intervention of representatives from the industry, the arts and cultural heritage, academia, research and innovation, and investment organizations.
More information on this event and agenda can be found here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
